SUBSCRIBE
SUBSCRIBE

Canada Bans Pfizer Inc. Arthritis Drug Bextra; Will Not Return To Market

December 16, 2005 | 
1 min read
OTTAWA, Dec 16 (Reuters) - Canada banned Pfizer Inc.'s (PFE.N: Quote, Profile, Research) arthritis drug Bextra on Friday because of risks of heart attacks and strokes.
Pfizer